DGJ-17229-98307
3 vaccinations
1 coded response
20 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 294 / SC
- Registered
- 2021-05-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-10
Dose 1 — Janssen/Johnson & Johnson
-
2021-05-11
Registered in v-safe
- 2021-06-09
- 2021-09-08
-
2021-11-04
Dose 2 — Pfizer-BioNTech
-
2021-11-05
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-11-06
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-11-07
- 2021-11-08
- 2021-11-09
- 2021-11-11
- 2021-11-18
- 2021-11-25
- 2021-12-02
- 2021-12-09
- 2021-12-16
- 2022-02-03
-
2022-05-05
Survey response — 6 months, dose 2MedDRA: COVID-19, Fatigue, Headache, Oropharyngeal pain, Pain — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: COVID-19, Sore throat, body aches, headache, fatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-05-05
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-05-06
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-10-14
Dose 3 — ModernaCo-administered: Flu
- 2022-11-04
- 2022-11-04
- 2022-11-11
- 2022-11-25
- 2023-01-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-10 | Janssen/Johnson & Johnson | |
| 2 | 2021-11-04 | Pfizer-BioNTech | No |
| 3 | 2022-10-14 | Moderna | Flu |
Call center
1 call center case
1 successful
Free text
Release 11 — 6 months, dose 2
Symptoms: COVID-19, Sore throat, body aches, headache, fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release